Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19
Clinical trial NCT06402279 · COMPLETED
Trial details
- NCT number
- NCT06402279
- Sponsor
- Efferon JSC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-01
- Primary completion
- 2022-02-28
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.